Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     infertility Treatment     Neurology Devices Market     Nerve Repair & Regeneration Market     Global Neurostimulation/Neuromodulation Market    
Real Time Market Research & Industry Analysis - MicroMarketMonitor

Internal Neurostimulation Market, by Type (Spinal Cord Stimulation, Deep brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Gastric Electric Stimulation), by Application (Parkinson’s Disease, Chronic Pain), by Geography – Analysis & Forecasts To 2019

  • Report Code: HE 1046
  • Publish Date: Apr 2015
  
Description
Table of Contents
Customer Intelligence
Summary
Inquiry Before Buying Ask for Discount

The objective of this report is to identify various types and usage patterns across industries, and to analyze the complete ecosystem of the internal neurostimulation market. It involves an in-depth analysis of the market segmentation, which comprises type, application, and geography. The report also provides an in-depth insight into varied growth strategies adopted by key players thriving in this market.

 

The internal neurostimulation market is segmented on the basis of types into spinal cord stimulation, deep brain stimulation, vagus nerve stimulation, sacral nerve stimulation, and gastric electric stimulation. With stringent IP regulations and increase in FDA approvals, the market is expected to witness a steady growth in the future.

 

Factors that have significantly contributed to the overall growth of the global neurostimulation market include research activities in the field of internal neurostimulation, growing awareness associated with the benefits of these techniques, government funding, and growing prevalence of neurological disorders.

 

The spinal cord stimulation segment accounted for the largest share of 57.5% in the global internal neurostimulation market in 2014. This segment was valued at $2,788.0 million in 2014, and is expected to reach $4,819.9 million by 2019, at a CAGR of 11.6% during the forecast period. The deep brain stimulation modality segment is the second-largest segment that was valued at $861.2 million in 2014, and is expected to reach $1,581.4 million by 2019, at a CAGR of 12.9% from 2014 to 2019. The vagus nerve stimulation (VNS) segment is expected to grow at a CAGR of 13.0% during the forecast period.

 

In-depth market share analysis of top companies is included in this report. These numbers are obtained based on key facts, annual financial information from SEC filings, annual reports, and interviews with industry experts and key opinion leaders, such as CEOs, directors, and marketing executives. In addition to this, the report has also profiled key market players with respect to varied parameters, such as business overview, financial overview, product portfolio, business strategies, and recent developments. Major companies of this market include Boston Scientific Corporation (U.S.), Cyberonics, Inc. (U.S.), Dynatronics Corporation (U.S.), EnteroMedics Inc. (U.S.), Medtronic Inc. (U.S.), and St. Jude Medical, Inc. (U.S.) among others.



Table of Contents

 

1 Introduction (Page No. - 10)
    1.1 Objectives of the Study
    1.2 Market Segmentation & Coverage
    1.3 Stakeholders

 

2 Research Methodology (Page No. - 13)
    2.1 Integrated Ecosystem of the Internal Neurostimulation Market
    2.2 Arriving at the Internal Neurostimulation Market Size
           2.2.1 Top-Down Approach
           2.2.2 Bottom-Up Approach
           2.2.3 Macroindicator-Based Approach
    2.3 Assumptions

 

3 Executive Summary (Page No. - 19)

 

4 Market Overview (Page No. - 21)
    4.1 Introduction
    4.2 Comparison With Parent Market
    4.3 Market Drivers and Inhibitors

 

5 Internal Neurostimulation Market, By Type (Page No. - 25)
    5.1 Introduction
    5.2 Global: Spinal Cord Stimulation Market, By Geography
    5.3 Global Deep Brain Stimulation Market, By Geography
    5.4 Global Sacral Nerve Stimulation Market, By Geography
    5.5 Sacral Nerve Stimulation Market, By Geography, 2013–2019 (USD MN)
    5.6 Global Vagus Nerve Stimulation Market, By Geography
    5.7 Global Gastric Electrical Stimulation Market, By Geography

 

6 Internal Neurostimulation Market, By Application (Page No. - 35)
    6.1 Introduction
    6.2 Global Internal Neurostimulation in Parkinson’s Disease ,  By Geography
    6.3 Global Internal Neurostimulation in Tremor, By Geography
    6.4 Global Internal Neurostimulation in Depression, By Geography
    6.5 Global Internal Neurostimulation in Other Applications ,  By Geography

 

7 Internal Neurostimulation Market, By Geography (Page No. - 43)
    7.1 Introduction
    7.2 North America Internal Neurostimulation Market
           7.2.1 North America Internal Neurostimulation Market,  By Application
           7.2.2 North America Internal Neurostimulation Market, By Type
    7.3 Europe Internal Neurostimulation Market
           7.3.1 Europe Internal Neurostimulation Market, By Application
           7.3.2 Europe Internal Neurostimulation Market, By Type
    7.4 Asia: Internal Neurostimulation Market
           7.4.1 Asia Internal Neurostimulation Market, By Application
           7.4.2 Asia Internal Neurostimulation Market, By Type
    7.5 RoW Internal Neurostimulation Market
           7.5.1 RoW Internal Neurostimulation Market, By Application
           7.5.2 RoW Internal Neurostimulation Market, By Type

 

8 Internal Neurostimulation Market: Competitive Landscape (Page No. - 59)
    8.1 Internal Neurostimulation Market: By Company
    8.2 Company Presence in Internal Neurostimulation Market, By Type
    8.3 New Product Launch
    8.4 Regulatory Approvals
    8.5 Agreements

 

9 Internal Neurostimulation Market, By Company (Page No. - 63)
    9.1 Boston Scientific Corporation (U.S.)
           1.1.1. Overview
           1.1.2. Key Financials:
           1.1.3. Product and Service Offerings
           1.1.4. Related Developments
           9.1.1 MMM View
    9.2 Cyberonics, Inc. (U.S.)
           9.2.1 Overview
           9.2.2 Key Financials
           9.2.3 Product and Service Offerings
           9.2.4 Related Developments
           9.2.5 MMM View
    9.3 Depuy Synthes Companies (U.S.)
           9.3.1 Overview
           9.3.2 Key Financials
           9.3.3 Product and Service Offerings
           9.3.4 Related Developments
           9.3.5 MMM View
    9.4 Enteromedics, Inc. (U.S.)
           9.4.1 Overview
           9.4.2 Key Financials
           9.4.3 Product and Service Offerings
           9.4.4 Related Developments
           9.4.5 MMM View
    9.5 Medtronic, Plc. (U.S.)
           9.5.1 Overview
           9.5.2 Key Financials
           9.5.3 Product and Service Offerings
           9.5.4 Related Developments
           9.5.5 MMM Analysis
    9.6 St. Jude Medical (U.S.)
           9.6.1 Overview
           9.6.2 Key Financials
           9.6.3 Product and Service Offerings
           9.6.4 Related Developments
           9.6.5 MMM View
    9.7 Synapse Biomedical, Inc. (U.S.)
           9.7.1 Overview
           9.7.2 Key Financials
           9.7.3 Product and Service Offerings
           9.7.4 Related Developments
           9.7.5 MMM View
    9.8 Uroplasty, Inc. (U.S.)
           9.8.1 Overview
           9.8.2 Key Financials
           9.8.3 Product and Service Offerings
           9.8.4 Related Developments
10 Appendix (Page No. - 84)
     10.1 Customization Options
             10.1.1 Product Analysis
             10.1.2 Epidemiology Data
             10.1.3 Surgeons/Physicians Perception Analysis
             10.1.4 Regulatory Framework
     10.2 Related Reports
     10.3 Introducing RT:  Real-Time Market Intelligence
             10.3.1 RT Snapshots

 

List of Tables (39 Tables)

 

Table 1 Global Internal Neurostimulation Peer Market Size, 2014 (USD MN)
Table 2 Macroindicators,  By Geography, 2014 (USD MN)
Table 3 Comparison With Parent Market, 2013-2019 (USD MN)
Table 4 Internal Neurostimulation Market, By Geography,  2014 (USD MN)
Table 5 Drivers and Inhibitors
Table 6 Global Internal Neurostimulation Market, By Type, 2013-2019 (USD MN)
Table 7 Spinal Cord Stimulation Market, By Geography, 2013–2019 (USD MN)
Table 8 Deep Brain Stimulation Market, By Geography, 2013–2019 (USD MN)
Table 9 Vagus Nerve Stimulation Market, By Geography, 2013–2019 (USD MN)
Table 10 Gastric Electrical Stimulation Masks Market, By Geography,2013–2019 (USD MN)
Table 11 Global Internal Neurostimulation Market, By Application,2013-2019 (USD MN)
Table 12 Global Internal Neurostimulation in Parkinson’s Disease,  By Geography, 2013-2019 (USD MN)
Table 13 Global Internal Neurostimulation in Tremor, By Geography,2013-2019 (USD MN)
Table 14 Global Internal Neurostimulation in Depression, By Geography,2013-2019(USD MN)
Table 15 Global Internal Neurostimulation in Other Applications,  By Geography, 2013-2019(USD MN)
Table 16 Global Internal Neurostimulation Market, By Geography,2013-2019 (USD MN)
Table 17 North America Internal Neurostimulation Market, By Application,2013-2019 (USD MN)
Table 18 North America Internal Neurostimulation Market, By Type,2013-2019 (USD MN)
Table 19 Europe Internal Neurostimulation Market, By Application,2013-2019 (USD MN)
Table 20 Europe: Internal Neurostimulation Market, By Type, 2013-2019 (USD MN)
Table 21 Asia Internal Neurostimulation Market, By Application,2013-2019 (USD MN)
Table 22 Asia Internal Neurostimulation Market, By Type, 2013-2019(USD MN)
Table 23 RoW Internal Neurostimulation Market, By Application,2013-2019 (USD MN)
Table 24 RoW Internal Neurostimulation Market, By Type, 2013-2019 (USD MN)
Table 25 Internal Neurostimulation Market, By Company
Table 26 Internal Neurostimulation Market: Company Share Analysis, 2013(%)
Table 27 Global Internal Neurostimulation Market: New Product Launch
Table 28 Global Internal Neurostimulation Market: Regulatory Approvals
Table 29 Global Internal Neurostimulation Market: Agreements
Table 30 Boston Scientific Corporation: Revenue, By Business Segment,2009 – 2013 (USD MN)
Table 31 Boston Scientific: Revenue, By Geographical Segments, 2009 – 2012 (USD MN)
Table 32 Cyberonics, Inc.: Key Financials, 2009 - 2013 (USD MN)
Table 33 Johnson & Johnson, Inc. : Revenue, By Business Segment,2009 - 2013 (USD MN)
Table 34 Johnson & Johnson, Inc.: Revenue, 2009 - 2013 (USD MN)
Table 35 Medtronic, Inc. : Revenue, By Business Segment, 2009 - 2013 (USD MN)
Table 36 Medtronic, Inc. : Revenue, By Geographical Segment,  2009 - 2013 (USD MN)
Table 37 St. Jude Medical: Revenue, By Business Segment, 2011 - 2013 (USD MN)
Table 38 St. Jude Medical: Revenue, By Geographical Segment,  2008 - 2013 (USD MN)
Table 39 Uroplasty, Inc. : Revenue, By Geographical Segment,  2011 - 2013 (USD MN)

 

List of Figures (45 Figures)

 

Figure 1 Segmentation & Coverage
Figure 2 Integrated Ecosystem
Figure 3 Research Methodology
Figure 4 Top-Down Approach
Figure 5 Bottom-Up Approach
Figure 6 Macroindicator Based Approach
Figure 7 Global Internal Neurostimulation Market Snapshot
Figure 8 Comparison With Parent Market
Figure 9 Global : Internal Neurostimulation Market, By Geography,2013–2019 (USD MN)
Figure 10 Global: Internal Neurostimulation Market, By Type,  2013–2019 (USD MN)
Figure 11 Global: Spinal Cord Stimulation Market, By Geography,2013–2019 (USD MN)
Figure 12 Global: Deep Brain Stimulation Market, By Geography,  2013–2019 (USD MN)
Figure 13 Global: Sacral Nerve Stimulation Market, By Geography,2013–2019 (USD MN)
Figure 14 Global: Vagus Nerve Stimulation Market, By Geography,2013–2019 (USD MN)
Figure 15 Global: Gastric Electrical Stimulation Masks Market, By Geography,2013–2019 (USD MN)
Figure 16 Global Internal Neurostimulation Market, By Application,2013-2019 (USD MN)
Figure 17 Global Internal Neurostimulation in Parkinson’s Disease,  By Geography, 2013-2019 (USD MN)
Figure 18 Global Internal Neurostimulation in Tremor, By Geography,2013-2019 (USD MN)
Figure 19 Global Internal Neurostimulation in Depression, By Geography,2013-2019 (USD MN)
Figure 20 Global Internal Neurostimulation in Other Applications,  By Geography, 2013-2019 (USD MN)
Figure 21 North America Internal Neurostimulation Market Overview,2014 & 2019 (%)
Figure 22 North America Internal Neurostimulation Market, By Application,2013-2019 (USD MN)
Figure 23 North America Internal Neurostimulation Market: Application Snapshot
Figure 24 North America Internal Neurostimulation Market, By Type,2013-2019 (USD MN)
Figure 25 North America Internal Neurostimulation Market Share,  By Type,2013-2019 (%)
Figure 26 Europe Internal Neurostimulation Market Overview, 2014 & 2019 (%)
Figure 27 Europe Internal Neurostimulation Market, By Application,2013-2019 (USD MN)
Figure 28 Europe Internal Neurostimulation Market: Application Snapshot
Figure 29 Europe Internal Neurostimulation Market, By Type, 2013-2019 (USD MN)
Figure 30 Europe: Internal Neurostimulation Market Share, By Type,  2013-2019 (%)
Figure 31 Asia Internal Neurostimulation Market Overview, 2014 & 2019 (%)
Figure 32 Asia Internal Neurostimulation Market, By Application,2013-2019 (USD MN)
Figure 33 Asia Internal Neurostimulation Market: Application Snapshot
Figure 34 Asia Internal Neurostimulation Market, By Type, 2013-2019 (USD MN)
Figure 35 Asia Internal Neurostimulation Market Share, By Type, 2013-2019 (%)
Figure 36 RoW Internal Neurostimulation Market Overview, 2014 & 2019 (%)
Figure 37 RoW Internal Neurostimulation Market, By Application,2013-2019 (USD MN)
Figure 38 RoW Internal Neurostimulation Market: Application Snapshot
Figure 39 RoW Internal Neurostimulation Market, By Type, 2013-2019(USD MN)
Figure 40 RoW:  Internal Neurostimulation Market Share, By Type, 2013-2019 (%)
Figure 41 Internal Neurostimulation: Company Product Coverage,  By Type, 2013
Figure 42 Boston Scientific Corporation Revenue Mix, 2013
Figure 43 Johnson & Johnson, Inc. Revenue Mix, 2013
Figure 44 Medtronic, Plc. Revenue Mix, 2013
Figure 45 St. Jude Medical. Revenue Mix, 2013

Neuromodulation treats a wide range of chronic and refractory disorders. The minimally invasive and non-invasive nature of this technique increases its adoptability, and thus it is considered as an outpatient procedure. Moreover, these therapies allow physicians to cease treatment by the removal of stimulating devices, as and when required.

 

The internal neurostimulation market is expected to grow owing to a wide range of factors, such as advancements in neurostimulation technology and effective outcomes associated with the adoption of spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, and vagus nerve stimulation.

 

The demand for internal neurostimulation has continued to remain robust across various regions. Rising prevalence of neurological disorders, increasing incidences of lower urinary tract syndrome, and rise in the percentage of patients suffering from cardiovascular disorders are considered as additional factors that have equally contributed to the overall growth of the global internal neurostimulation market.

 

In addition to all the above mentioned factors, the growing prevalence of lower urinary tract diseases has created new growth opportunities for this market. It was estimated that by 2018, 2.3 billion individuals will be affected by at least one type of lower urinary tract symptoms, such as overactive bladder (OAB) or urinary incontinence (UI).

 

The neurostimulation therapy is becoming a part of clinical armamentarium to treat a variety of lower urinary tract conditions in female urology. Its increased usage stems from the need of patients, who have exhausted all other therapeutic options for the treatment of lower urinary tract disorders. However, the unfavourable reimbursement scenario and dearth of trained personals are factors hindering the growth of this market.

 

Major players operating in the global internal neurostimulation market include Boston Scientific Corporation (U.S.), Cyberonics, Inc. (U.S.), Dynatronics Corporation (U.S.), EnteroMedics Inc. (U.S.), Medtronic Inc. (U.S.), and St. Jude Medical, Inc. (U.S.), among others.

Custom Market Research Services
We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
PRODUCT TITLE PUBLISHED
Asian Internal Neurostimulation Asian Internal Neurostimulation
The Asian internal neurostimulation market was $271.80 million in 2013, and expected to reach $546.6 million by 2018 at a CAGR of 15.0%. Internal Neurostimulation market segmented by 5 modalities includes spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS), gastric electrical stimulation (GES). Major players dominating the Internal Neurostimulation market are Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical (U.S.), Johnson & Johnson and Greenbatch Inc,.
Mar 2015
European Internal Neurostimulation European Internal Neurostimulation
The European internal neurostimulation market was $947.8 million in 2013, and is expected to reach $1715.8 million by 2018 at a CAGR of 13.0%. Internal Neurostimulation market segmented by 5 modalities includes spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS), gastric electrical stimulation (GES). Major players dominating the Internal Neurostimulation market are Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical (U.S), and Neuronetics, Inc (U.S.). Emerging players in this market include Biocontrol Medical, ANM Neuromodulation GmbH and Magstim Company Limited.
Upcoming
North American Internal Neurostimulation North American Internal Neurostimulation
The North American Internal Neurostimulation market was $2548.27 million in 2013 and expected to reach $4242.09 million by 2018 at a CAGR of 10.7%. Internal Neurostimulation market segmented by 5 modalities includes spinal cord stimulation (SCS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), sacral nerve stimulation (SNS), gastric electrical stimulation (GES). Major players dominating the Internal Neurostimulation market include Medtronic, Boston Scientific, St. Jude Medical, Cyberonics, Enteromedics, Neurotech, Cerebomed, Microtransponder and BioControl Medical.
Upcoming
Spinal cord stimulator Spinal cord stimulator
Spinal cord stimulator and Deep Brain Stimulator, Sacral...
Upcoming
Deep Brain Stimulator Deep Brain Stimulator
Deep Brain Stimulator and Spinal cord stimulator,
Upcoming
Sacral Nerve Stimulator Sacral Nerve Stimulator
Sacral Nerve Stimulator and Spinal cord stimulator, Deep...
Upcoming
Vagus Nerve Stimulator Vagus Nerve Stimulator
Vagus Nerve Stimulator and Spinal cord stimulator, Deep...
Upcoming
Gastric Electrical stimulator Gastric Electrical stimulator
Gastric Electrical stimulator and Spinal cord stimulator,
Upcoming
Middle East & Africa Internal Neurostimulation/Neuromodulation Market Middle East & Africa Internal Neurostimulation/Neuromodulation Market
The emerging markets such as Saudi Arabia, South Africa, and Turkey have become attractive for companies engaged in the development and marketing of the internal neuromodulation implants.
Feb 2015
Asia-Pacific Internal Neurostimulation/ Neuromodulation Devices Asia-Pacific Internal Neurostimulation/ Neuromodulation Devices
Peers of Internal Neurostimulation/ Neuromodulation Devices - Asia-Pacific are Sacral Nerve Stimulator, Spinal Cord Stimulator, Deep Brain Stimulator and Vagus Nerve Stimulator comprising 5.1%, 0.0%, 0.0% and 0.0% respectively of the Global Internal Neurostimulation/...
Upcoming
10 of 10 items
10 reports | Show
Connect With Us
US/CAN : +1-888-502-0539